Catherine Spier

5.2k total citations · 1 hit paper
73 papers, 3.6k citations indexed

About

Catherine Spier is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Catherine Spier has authored 73 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pathology and Forensic Medicine, 31 papers in Oncology and 21 papers in Genetics. Recurrent topics in Catherine Spier's work include Lymphoma Diagnosis and Treatment (45 papers), Chronic Lymphocytic Leukemia Research (19 papers) and Viral-associated cancers and disorders (9 papers). Catherine Spier is often cited by papers focused on Lymphoma Diagnosis and Treatment (45 papers), Chronic Lymphocytic Leukemia Research (19 papers) and Viral-associated cancers and disorders (9 papers). Catherine Spier collaborates with scholars based in United States, Netherlands and Malaysia. Catherine Spier's co-authors include Thomas M. Grogan, Thomas P. Miller, Richard I. Fisher, Michael LeBlanc, William S. Dalton, TP Miller, Ellen Chase, David J. Adelstein, Steve Dahlberg and J. Robert Cassady and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Catherine Spier

70 papers receiving 3.5k citations

Hit Papers

Chemotherapy Alone Compared with Chemotherapy plus Radiot... 1998 2026 2007 2016 1998 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Chemotherapy Alone Compared with Chemotherapy plus Radiotherapy for Localized Intermediate- and High-Grade Non-Hodgkin's Lymphoma
    1998 712 citations Thomas P. Miller, Catherine Spier et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Spier United States 30 2.0k 1.8k 857 671 620 73 3.6k
Yoshitoyo Kagami Japan 35 1.9k 0.9× 2.3k 1.2× 739 0.9× 705 1.1× 521 0.8× 102 3.9k
TM Grogan United States 26 2.0k 1.0× 1.4k 0.8× 1.0k 1.2× 711 1.1× 315 0.5× 58 3.6k
TP Miller United States 22 2.0k 1.0× 1.8k 1.0× 766 0.9× 695 1.0× 508 0.8× 28 3.3k
Roberto Giardini Italy 32 1.2k 0.6× 1.7k 0.9× 661 0.8× 671 1.0× 569 0.9× 84 3.2k
Hartmut Kirchner Germany 32 1.9k 1.0× 1.7k 1.0× 1.3k 1.6× 826 1.2× 553 0.9× 117 5.0k
Michael Millenson United States 22 3.0k 1.5× 2.0k 1.1× 425 0.5× 747 1.1× 619 1.0× 64 4.5k
Hans–Konrad Müller–Hermelink Germany 31 1.3k 0.7× 2.1k 1.1× 580 0.7× 607 0.9× 959 1.5× 64 3.9k
J Garcı́a-Conde Spain 35 2.0k 1.0× 1.1k 0.6× 954 1.1× 792 1.2× 168 0.3× 104 3.9k
Mark Roschewski United States 25 1.3k 0.7× 1.4k 0.8× 779 0.9× 627 0.9× 368 0.6× 131 2.9k
Andrei R. Shustov United States 34 2.5k 1.3× 3.3k 1.8× 907 1.1× 790 1.2× 470 0.8× 158 5.3k

Countries citing papers authored by Catherine Spier

Since Specialization
Citations

This map shows the geographic impact of Catherine Spier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Spier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Spier more than expected).

Fields of papers citing papers by Catherine Spier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Spier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Spier. The network helps show where Catherine Spier may publish in the future.

Co-authorship network of co-authors of Catherine Spier

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Spier. A scholar is included among the top collaborators of Catherine Spier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Spier. Catherine Spier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tome, Margaret E., Dean Billheimer, Catherine Spier, et al.. (2024). Optimizing assessment of CD30 expression in Hodgkin lymphoma by controlling for low expression.. PubMed. 39(3). 319–331. 1 indexed citations
2.
Shadman, Mazyar, Lisa M. Rimsza, John P. Leonard, et al.. (2023). A “FUNCTIONAL CURE” MAY BE ACHIEVABLE IN A SUBSET OF PATIENTS WITH FOLLICULAR LYMPHOMA TREATED WITH CHEMOIMMUNOTHERAPY: 15‐YEAR FOLLOW‐UP OF PHASE III SWOG‐S0016. Hematological Oncology. 41(S2). 116–117. 1 indexed citations
3.
Burack, Richard, Hongli Li, Diana G. Adlowitz, et al.. (2023). Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphoma. Blood Advances. 7(17). 5082–5090. 6 indexed citations
4.
5.
Barr, Paul M., Hongli Li, Catherine Spier, et al.. (2015). Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108. Journal of Clinical Oncology. 33(21). 2399–2404. 91 indexed citations
6.
Chen, Liu Qi, Christine M. Howison, Catherine Spier, et al.. (2014). Assessment of carbonic anhydrase IX expression and extracellular pH in B-cell lymphoma cell line models. Leukemia & lymphoma. 56(5). 1432–1439. 31 indexed citations
7.
Barr, Paul M., Hongli Li, Catherine Spier, et al.. (2014). U.S. Intergroup phase II trial (SWOG 1108) of alisertib, an investigational aurora A kinase (AAK) inhibitor, in patients with peripheral T-cell lymphoma (PTCL; NCT01466881).. Journal of Clinical Oncology. 32(15_suppl). 8523–8523. 9 indexed citations
8.
Press, Oliver W., Joseph M. Unger, Lisa M. Rimsza, et al.. (2013). A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP–Rituximab versus CHOP + 131Iodine—Tositumomab. Clinical Cancer Research. 19(23). 6624–6632. 32 indexed citations
9.
Press, Oliver W., Joseph M. Unger, Lisa M. Rimsza, et al.. (2012). Phase III Randomized Intergroup Trial of CHOP Plus Rituximab Compared With CHOP Chemotherapy Plus 131 Iodine-Tositumomab for Previously Untreated Follicular Non-Hodgkin Lymphoma: SWOG S0016. Journal of Clinical Oncology. 31(3). 314–320. 123 indexed citations
10.
11.
Miller, Thomas P., Catherine Spier, & Lisa M. Rimsza. (2006). Diffuse Aggressive Histologies of Non-Hodgkin Lymphoma: Treatment and Biology of Limited Disease. Seminars in Hematology. 43(4). 207–212. 9 indexed citations
12.
Spier, Catherine, Michael LeBlanc, Ellen Chase, Richard I. Fisher, & Thomas P. Miller. (2004). Histologic Subtypes Do Not Confer Unique Outcomes in Early-Stage Lymphoma: Long-Term Follow-Up of SWOG 8736.. Blood. 104(11). 3263–3263. 3 indexed citations
13.
Spier, Catherine, et al.. (1993). NCAM (CD56)-Positive Malignant Lymphoma. Leukemia & lymphoma. 12(1-2). 1–10. 54 indexed citations
14.
List, Alan F. & Catherine Spier. (1992). Multidrug Resistance in Acute Leukemia: A Conserved Physiologic Function. Leukemia & lymphoma. 8(1-2). 9–14. 7 indexed citations
15.
List, Alan F., Catherine Spier, Donald C. Doll, et al.. (1991). Expression of the multidrug resistance gene product (P‐glycoprotein) in myelodysplasia is associated with a stem cell phenotype. British Journal of Haematology. 78(1). 28–34. 106 indexed citations
16.
17.
Lippman, Scott M., et al.. (1988). Clonal ambiguity of human immunodeficiency virus-associated lymphomas. Similarity to posttransplant lymphomas.. PubMed. 112(2). 128–32. 19 indexed citations
18.
Miller, TP, Scott M. Lippman, Catherine Spier, Donald J. Slymen, & Thomas M. Grogan. (1988). HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphoma.. Journal of Clinical Investigation. 82(1). 370–372. 82 indexed citations
19.
Bedotto, John B., Catherine Spier, M Paquin, et al.. (1986). Mantle zone lymphoma with central nervous system involvement. Cancer. 58(9). 2125–2129. 13 indexed citations
20.
Grogan, Thomas M., Catherine Spier, Daniel P. Wirt, et al.. (1985). Immunotopographic assessment of lymphoid and plasma cell malignancies in the bone marrow. Human Pathology. 16(12). 1247–1254. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshitoyo Kagami Breakdown of academic impact, for papers by TM Grogan Breakdown of academic impact, for papers by TP Miller Breakdown of academic impact, for papers by Roberto Giardini Breakdown of academic impact, for papers by Hartmut Kirchner Breakdown of academic impact, for papers by Michael Millenson Breakdown of academic impact, for papers by Hans–Konrad Müller–Hermelink Breakdown of academic impact, for papers by J Garcı́a-Conde Breakdown of academic impact, for papers by Mark Roschewski Breakdown of academic impact, for papers by Andrei R. Shustov
Rankless by CCL
2026